Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -22.03% | -55.79% | -30.00% | 7.94% | -24.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.03% | -55.79% | -30.00% | 7.94% | -24.36% |
| Cost of Revenue | 47.71% | -32.91% | -1.06% | 51.23% | -12.57% |
| Gross Profit | -91.49% | 17.27% | -20.18% | -78.79% | 3.09% |
| SG&A Expenses | -10.33% | -45.08% | 46.28% | -6.10% | 39.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.25% | -33.03% | 45.17% | 8.47% | 28.42% |
| Operating Income | -4.57% | 32.71% | -46.94% | -8.48% | -29.51% |
| Income Before Tax | 20.29% | 5.66% | -481.32% | 70.20% | 52.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.29% | 5.66% | -481.32% | 70.20% | 52.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.29% | 5.66% | -481.32% | 70.20% | 52.69% |
| EBIT | -4.57% | 32.71% | -46.94% | -8.48% | -29.51% |
| EBITDA | -4.04% | 32.94% | -46.75% | -8.25% | -29.54% |
| EPS Basic | 28.77% | -40.99% | -381.14% | 79.29% | 68.65% |
| Normalized Basic EPS | 30.47% | -8.08% | 7.05% | 84.61% | 11.95% |
| EPS Diluted | 28.77% | -41.55% | -398.88% | 79.29% | 68.66% |
| Normalized Diluted EPS | 30.47% | -8.08% | -2.04% | 84.61% | 11.95% |
| Average Basic Shares Outstanding | 14.66% | -12.69% | 92.05% | 93.63% | 83.75% |
| Average Diluted Shares Outstanding | 14.66% | -12.69% | 74.91% | 93.63% | 83.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |